Studying synergistic anticancer effects of repurposed AT1B losartan with antidiabetics metformin, rosiglitazone in triple-negative breast cancer cells

European Journal of Pharmacology 2026

View at publisher

Authors: Zakariya Al-Mashhadani, Yassir Mustafa Kamal Al Mulla Hummadi, Wrood S. AL-khfajy, Nawfal A. Numan

DOI: 10.1016/j.ejphar.2026.178857

Cited by: 1

References: 47

Fields of Study & Subjects

Metabolism Diabetes and Cancer Peroxisome Proliferator-Activated Receptors Protein Kinase Regulation and GTPase Signaling

References 47